Highlights
NASDAQ: LPTX       Leap Therapeutics Inc
Last Price Today's Change   Day's Range   Trading Volume
1.79   -0.08 (4.28%)  1.75 - 1.90  315,600

Overview

 
Avg Volume (4 weeks):1,560,305
4 Weeks Range:1.02 - 2.07
4 Weeks Price Volatility (%):
73.33%
52 Weeks Range:0.57 - 3.30
52 Weeks Price Volatility (%):
44.69%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Leap Therapeutics Inc is a biopharmaceutical company. The company is acquiring and developing novel therapeutics at the leading edge of cancer biology. Its programs are monoclonal antibodies that target key cellular pathways that enable cancer to grow and spread and specific mechanisms that activate the body's immune system to identify and attack cancer. Leap has two clinical stage programs: DKN-01 and TRX518. DKN-01 is a monoclonal antibody targeting Dickkopf-related protein 1, or DKK1, a protein that regulates important cell signaling pathways, known as the Wnt pathways. TRX518 is a monoclonal antibody targeting the glucocorticoid-induced tumor necrosis factor-related receptor, or GITR, a receptor found on the surface of a wide range of immune cells.

  Be the first to like this.
 


 

2885  5191  592  230 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.79-0.38 
 FCEL 2.22-0.66 
 CHK 0.593-0.004 
 AVP 5.60-0.05 
 GE 11.37-0.29 
 EEM 45.43+0.37 
 NTRP 1.42-0.03 
 SPY 331.34+0.04 
 FXI 43.47+0.48 
 GNPX 1.89+0.74 
Partners & Brokers